Biobanking Market Size 2022-27: Report, Share, Industry Growth, Analysis, Trends and Forecast
According to the latest report by IMARC Group, titled " Biobanking Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 ", it is expected to reached a value of US$ 53.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 77.6 Billion by 2027 exhibiting a CAGR of 6.18% during 2022-2027. Biobanking refers to the procedure of storing and analyzing information about human biospecimens, which are collected from people with a particular condition or healthy volunteers. Biobanks are of two types, namely, population-based and disease-oriented. These modern procedures involve the large-scale analysis of specific disease biomarkers, which include digital or biological materials with well-annotated clinical data. Biobanking provides a basis for improving personalized medical approaches wherein effective identification is crucial for diagnosis and prognosis. As a result, these procedures find extensive utilization ...